ARCHIVES

NCI Sends Letter To Grantees To Explain Tighter Funding.

This article is from The Cancer Letter archive.

Vol. 27 No. 11 | March 16, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: extramural Affairs Director Diggs to Leave NIH; Bonadonna, Fisher Share Bristol-Meyer Award

April 2, 1993

Aromasin Approved By FDA For ER+ Early Breast Cancer

October 28, 2005

J&J To Eliminate Its Ortho Biotech Unit As FDA Considers Further Limits On ESAs.

May 2, 2008

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

Zytiga and Prednisone Extends Overall Survival in mCRPC Trial

October 31, 2014

FDA Selects 23 Survivors To Review Drug Applications.

June 15, 2001